氟烷在人体内生物转化的差异。 - Suppr

Suppr

超能文献

Differences in the biotransformation of halothane in man.

作者信息

Cascorbi H F, Blake D A, Helrich M

出版信息

Anesthesiology. 1970 Feb;32(2):119-23. doi: 10.1097/00000542-197002000-00006.

DOI:10.1097/00000542-197002000-00006

PMID:5414289

Abstract

摘要

相似文献

Differences in the biotransformation of halothane in man.

Anesthesiology. 1970 Feb;32(2):119-23. doi: 10.1097/00000542-197002000-00006.

Factors causing differences in halothane biotransformation.

Int Anesthesiol Clin. 1974 Summer;12(2):63-71. doi: 10.1097/00004311-197412020-00008.

Absorption, biotransformation, and storage of halothane.

Environ Health Perspect. 1977 Dec;21:165-9. doi: 10.1289/ehp.7721165.

Studies with halothane. I. The distribution and excretion of halothane metabolites in animals.

Anesthesiology. 1972 Sep;37(3):311-23.

Percutaneous loss of nitrous oxide, cyclopropane, ether and halothane in man.

Anesthesiology. 1969 Mar;30(3):278-83. doi: 10.1097/00000542-196903000-00008.

The biotransformation of halothane.

Ann R Coll Surg Engl. 1971 Feb;48(2):78.

Metabolism of halothane-2 14C in the mouse.

Anesthesiology. 1969 Dec;31(6):560-5. doi: 10.1097/00000542-196912000-00009.

Trifluoroethanol and halothane biotransformation in man.

Anesthesiology. 1971 Nov;35(5):493-5. doi: 10.1097/00000542-197111000-00008.

Biotransformation of halothane.

Int Anesthesiol Clin. 1974 Summer;12(2):41-53. doi: 10.1097/00004311-197412020-00006.

Halothane reductive metabolism in an adult surgical population.

Anaesth Intensive Care. 1990 Aug;18(3):395-9. doi: 10.1177/0310057X9001800318.

引用本文的文献

Inhaled volatile anesthetics in the intensive care unit.

World J Crit Care Med. 2024 Mar 9;13(1):90746. doi: 10.5492/wjccm.v13.i1.90746.

Excretion of trifluoroacetic acid as a metabolite of halothane in digestive juices.

J Anesth. 1988 Sep 1;2(2):133-8. doi: 10.1007/s0054080020133.

Anaesthetic considerations for microsurgical repair of limbs.

Can Anaesth Soc J. 1984 Jan;31(1):51-60. doi: 10.1007/BF03011483.

The biotransformation of halothane.

Ann R Coll Surg Engl. 1971 Feb;48(2):78.

The halothane dilemma: a case for the defence.

Br Med J. 1971 Oct 9;4(5779):96-100. doi: 10.1136/bmj.4.5779.96.

Anaesthetic contamination.

Br Med J. 1973 Apr 14;2(5858):113. doi: 10.1136/bmj.2.5858.113.

Anaesthetic contamination.

Br Med J. 1973 Mar 24;1(5855):693-4.

Biotransformation of volatile anaesthetics with special emphasis on the role of metabolism in the toxicity of anaesthetics.

Can Anaesth Soc J. 1973 Jan;20(1):21-33. doi: 10.1007/BF03025562.

Chronic exposure to anaesthetics: a toxicity problem?

Can Anaesth Soc J. 1973 Jan;20(1):104-20. doi: 10.1007/BF03025569.

Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.

Naunyn Schmiedebergs Arch Pharmacol. 1973;279(1):39-52. doi: 10.1007/BF00502066.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Differences in the biotransformation of halothane in man.

Anesthesiology. 1970 Feb;32(2):119-23. doi: 10.1097/00000542-197002000-00006.

Factors causing differences in halothane biotransformation.

Int Anesthesiol Clin. 1974 Summer;12(2):63-71. doi: 10.1097/00004311-197412020-00008.

Absorption, biotransformation, and storage of halothane.

Environ Health Perspect. 1977 Dec;21:165-9. doi: 10.1289/ehp.7721165.

Studies with halothane. I. The distribution and excretion of halothane metabolites in animals.

Anesthesiology. 1972 Sep;37(3):311-23.

Percutaneous loss of nitrous oxide, cyclopropane, ether and halothane in man.

Anesthesiology. 1969 Mar;30(3):278-83. doi: 10.1097/00000542-196903000-00008.

The biotransformation of halothane.

Ann R Coll Surg Engl. 1971 Feb;48(2):78.

Metabolism of halothane-2 14C in the mouse.

Anesthesiology. 1969 Dec;31(6):560-5. doi: 10.1097/00000542-196912000-00009.

Trifluoroethanol and halothane biotransformation in man.

Anesthesiology. 1971 Nov;35(5):493-5. doi: 10.1097/00000542-197111000-00008.

Biotransformation of halothane.

Int Anesthesiol Clin. 1974 Summer;12(2):41-53. doi: 10.1097/00004311-197412020-00006.

Halothane reductive metabolism in an adult surgical population.

Anaesth Intensive Care. 1990 Aug;18(3):395-9. doi: 10.1177/0310057X9001800318.

引用本文的文献

Inhaled volatile anesthetics in the intensive care unit.

World J Crit Care Med. 2024 Mar 9;13(1):90746. doi: 10.5492/wjccm.v13.i1.90746.

Excretion of trifluoroacetic acid as a metabolite of halothane in digestive juices.

J Anesth. 1988 Sep 1;2(2):133-8. doi: 10.1007/s0054080020133.

Anaesthetic considerations for microsurgical repair of limbs.

Can Anaesth Soc J. 1984 Jan;31(1):51-60. doi: 10.1007/BF03011483.

The biotransformation of halothane.

Ann R Coll Surg Engl. 1971 Feb;48(2):78.

The halothane dilemma: a case for the defence.

Br Med J. 1971 Oct 9;4(5779):96-100. doi: 10.1136/bmj.4.5779.96.

Anaesthetic contamination.

Br Med J. 1973 Apr 14;2(5858):113. doi: 10.1136/bmj.2.5858.113.

Anaesthetic contamination.

Br Med J. 1973 Mar 24;1(5855):693-4.

Biotransformation of volatile anaesthetics with special emphasis on the role of metabolism in the toxicity of anaesthetics.

Can Anaesth Soc J. 1973 Jan;20(1):21-33. doi: 10.1007/BF03025562.

Chronic exposure to anaesthetics: a toxicity problem?

Can Anaesth Soc J. 1973 Jan;20(1):104-20. doi: 10.1007/BF03025569.

Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.

Naunyn Schmiedebergs Arch Pharmacol. 1973;279(1):39-52. doi: 10.1007/BF00502066.